Abstract 6931: Epigenetic Modification of the Von Willebrand Factor Promotor Drives in situ Thrombosis in Chronic Thromboembolic Pulmonary Hypertension

Xue D. Manz,Robert Szulcek,Xiaoke Pan,Petr Symersky,Chris Dickhoff,Jisca Majolée,Veerle Kremer,Elisabetta Michielon,Ekatarina S. Jordanova,Teodora Radonic,Irene V. Bijnsdorp,Sander R. Piersma,Thang V. Pham,Connie R. Jimenez,Frances S. de Man,Reinier A. Boon,Jan Voorberg,Peter L. Hordijk,Jurjan Aman,Harm-Jan Bogaard

Abstract 6931: Epigenetic Modification of the Von Willebrand Factor Promotor Drives in situ Thrombosis in Chronic Thromboembolic Pulmonary Hypertension

2021

Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by thromboembolic obstructions of the pulmonary circulation; disease progression may involve in situ thrombosis. C...

Keywords:

Cardiology
Endothelium
Thrombosis
Chronic thromboembolic pulmonary hypertension
Pulmonary hypertension
Internal medicine
Epigenetics
Pulmonary embolism
disease progression
Von Willebrand factor
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations